US SB1209 | 2019-2020 | 116th Congress
Status
Spectrum: Slight Partisan Bill (Democrat 5-3)
Status: Introduced on April 11 2019 - 25% progression, died in committee
Action: 2019-04-11 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on April 11 2019 - 25% progression, died in committee
Action: 2019-04-11 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to approval of abbreviated new drug applications.
Title
REMEDY Act Reforming Evergreening and Manipulation that Extends Drug Years Act
Sponsors
Sen. Bill Cassidy [R-LA] | Sen. Richard Durbin [D-IL] | Sen. Lisa Murkowski [R-AK] | Sen. Kevin Cramer [R-ND] |
Sen. Tina Smith [D-MN] | Sen. Jeanne Shaheen [D-NH] | Sen. Jeff Merkley [D-OR] | Sen. Gary Peters [D-MI] |
History
Date | Chamber | Action |
---|---|---|
2019-04-11 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Same As/Similar To
HB3812 (Same As) 2019-07-18 - Referred to the Subcommittee on Health.
Subjects
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/116th-congress/senate-bill/1209/all-info |
Text | https://www.congress.gov/116/bills/s1209/BILLS-116s1209is.pdf |